Compare LNTH & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | LUMN |
|---|---|---|
| Founded | 1956 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.2B |
| IPO Year | 2014 | 1994 |
| Metric | LNTH | LUMN |
|---|---|---|
| Price | $100.37 | $4.85 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 10 |
| Target Price | ★ $106.99 | $7.49 |
| AVG Volume (30 Days) | 965.7K | ★ 14.1M |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | $343,374,000.00 | ★ $12,402,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.85 | N/A |
| P/E Ratio | $34.49 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $50.16 | $4.25 |
| 52 Week High | $111.86 | $11.45 |
| Indicator | LNTH | LUMN |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 43.18 |
| Support Level | $100.33 | $4.25 |
| Resistance Level | $100.43 | $6.87 |
| Average True Range (ATR) | 0.38 | 0.30 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 74.65 | 74.39 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017, the 2022 divestiture of much of its local phone business in rural areas, and the 2026 sale of its remaining consumer fiber network to AT&T have shifted the company's operations away from the legacy consumer business and toward enterprise services, which account for about 85%-90% of revenue. Lumen offers businesses a full suite of communications services, providing colocation and data center services, data transportation, phone service, and internet access.